Reducing the Burden of Hypoglycemia in Type 1 Diabetes: The Impact of FLO23011 on Patient-Reported Outcomes and Glycemic Correlates of Treatment Response.
Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
Beta-hydroxybutyrateContinuous glucose monitoringFLO23011HypoglycemiaHypoglycemia recoveryPatient-reported outcomesType 1 diabetesPatient-reported OutcomesType 1 DiabetesFlo23011Hypoglycemia Recovery
Come citare questo studio
David Russell-Jones, Eliza G Meehan, Vera Smout, Sabyasachi Roy, Wendy Frost, Tim M Young, David B Bartlett. (2026). Reducing the Burden of Hypoglycemia in Type 1 Diabetes: The Impact of FLO23011 on Patient-Reported Outcomes and Glycemic Correlates of Treatment Response.. Diabetes therapy : research, treatment and education of diabetes and related disorders. DOI: 10.1007/s13300-026-01929-6
Consulta la pubblicazione originale ↗